Halozyme Therapeutics Inc (NASDAQ:HALO)

22.10
Delayed Data
As of Jul 02
 -0.40 / -1.78%
Today’s Change
7.51
Today|||52-Week Range
23.16
+129.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.8B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders33.98%
Other institutional32.51%
Individual stakeholders21.88%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account